Skip to main content
. Author manuscript; available in PMC: 2013 Dec 4.
Published in final edited form as: Invest New Drugs. 2009 Jul 2;28(5):10.1007/s10637-009-9279-8. doi: 10.1007/s10637-009-9279-8

Table 2.

Patient characteristics

Age Median (Range) 57 (40–72)
Sex Female 14
Male 4
Performance Status 1 17
2 1
Diagnosis Ovary 6
Colon 4
Breast 2
Cervical 2
Others* 4
# prior chemotherapy regimens 1–3 6
4–8 8
≥9 4
*

Others: leiomyosarcoma (1), carcinoid (1), prostate (1), non small cell lung cancer (1)